Literature DB >> 21092788

Branched endografts for thoracoabdominal aneurysms.

Roy Greenberg1, Matthew Eagleton, Tara Mastracci.   

Abstract

PURPOSE: Endovascular management of thoracoabdominal aneurysms has been studied since 2001, with marked advances allowing for the treatment of complex anatomic situations including chronic aortic dissections, tortuous anatomy, and extensive aneurysms that involve the visceral segment, aortic arch, and iliacs as well. However, the technology is not widely disseminated, and a thorough understanding of the engineering principles, imaging techniques, and devices available is required.
METHODS: Reinforced fenestrated branches coupled with balloon expandable stent grafts, and side-arm branch designs mated with self-expanding stent grafts have been used. Pure fenestrated designs were used for juxtarenal aneurysms, whereas thoracoabdominal aneurysms were treated with reinforced fenestrated branches or hybrid devices including side-arm branches and reinforced fenestrated branches. Intraoperative fusion techniques have been used since 2009, whereby preoperative computed tomographic data are fused with intraoperative fluoroscopy. Long-term survival in accordance with extent of disease was assessed with life table analysis techniques, and differences were analyzed using the log rank test. Intermediate-term data pertaining to patency related to both types of branches and paraplegia have been evaluated and previously published.
RESULTS: A total of 406 patients with thoracoabdominal aneurysms and 227 patients with juxtarenal aneurysms have been enrolled in a prospective study. Perioperative and 2-year survival were most closely related to extent of initial disease and were estimated to be 1.8% and 82% for juxtarenal aneurysms, 2.3% and 82% for type IV, and 5.2% and 74% for type II and III thoracoabdominal aneurysms at 24 months, respectively. When patients undergoing endovascular repair (ER group) were matched with those having contemporary surgical repair (SR group) for anatomic disease extent, mortality was similar at 30 days (5.7% ER vs 8.3% SR; P = .2) and at 12 months (15.6% ER vs 15.9% SR; P = .9). Paraplegia risk was also similar between the 2 groups (4.3% ER vs 7.5% SR, respectively; P = .08). Among the 633 patients, there were 5 (0.8%) late ruptures at a mean of 18 months after treatment, of which 4 were fatal. They were attributed to component separation (n = 3), a remote aneurysm rupture proximal to the endovascular repair, and a failed surgical polyester graft distal to the repair. Reinforced fenestrated branch patency, when coupled with balloon-expandable stent grafts, was 97.8% at a mean follow-up of 15 months. Side-arm branch occlusion occurred in only 1 case, within 24 hours of the procedure. New imaging tools resulted in a marked reduction in the average contrast dose (>50%).
CONCLUSIONS: Intermediate-term results with multiple methods of endovascular repair of thoracoabdominal aneurysm indicate the technical feasibility of the procedure and show great promise in patients considered at high risk for open surgery. The intermediate-term patency and survival are excellent, and ruptures are exceedingly uncommon. However, mortality and spinal cord ischemia risks are still considerable with this technique.
Copyright © 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21092788     DOI: 10.1016/j.jtcvs.2010.07.061

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  27 in total

Review 1.  Debranching aortic surgery.

Authors:  Manuel Alonso Pérez; José Manuel Llaneza Coto; José Antonio Del Castro Madrazo; Carlota Fernández Prendes; Mario González Gay; Amer Zanabili Al-Sibbai
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Endovascular repair of the ascending aorta: the last frontier?

Authors:  Drosos Kotelis; Johannes Kalder; Michael J Jacobs
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

3.  Survival and patient-centered outcome in a disease-based observational cohort study of patients with thoracoabdominal aortic aneurysm.

Authors:  P Chulhi Kang; Matthew A Bartek; Sherene Shalhub; Derek P Nathan; Matthew P Sweet
Journal:  J Vasc Surg       Date:  2019-05-27       Impact factor: 4.268

Review 4.  [Aneurysms of the thoracic and thoracoabdominal aorta].

Authors:  J Zanow; U Settmacher
Journal:  Chirurg       Date:  2014-09       Impact factor: 0.955

5.  Open Repair of Thoracoabdominal Aortic Aneurysm in a 46-Year-Old Man with Pleural Adhesions and Aberrant Right Subclavian Artery.

Authors:  Jae Hyun Kim; Kyung Sub Song; Jae Bum Kim
Journal:  Tex Heart Inst J       Date:  2018-06-01

Review 6.  The Current State of Fenestrated and Branched Devices for Abdominal Aortic Aneurysm Repair.

Authors:  Holly L Graves; Benjamin M Jackson
Journal:  Semin Intervent Radiol       Date:  2015-09       Impact factor: 1.513

7.  Three-dimensional fusion computed tomography decreases radiation exposure, procedure time, and contrast use during fenestrated endovascular aortic repair.

Authors:  Michael M McNally; Salvatore T Scali; Robert J Feezor; Daniel Neal; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2014-08-28       Impact factor: 4.268

Review 8.  Visceral Debranching for the Treatment of Thoracoabdominal Aortic Aneurysms: Based on a Presentation at the 2013 VEITH Symposium, November 19-23, 2013 (New York, NY, USA).

Authors:  Scott M Damrauer; Ron M Fairman
Journal:  Aorta (Stamford)       Date:  2015-04-01

9.  Thoracoabdominal aortic aneurysm (extent II) repair in a patient with systemic vasculitis.

Authors:  Jae Hyun Kim
Journal:  J Vis Surg       Date:  2016-03-09

10.  Image guidance for endovascular repair of complex aortic aneurysms: comparison of two-dimensional and three-dimensional angiography and image fusion.

Authors:  Vania Tacher; MingDe Lin; Pascal Desgranges; Jean-Francois Deux; Thijs Grünhagen; Jean-Pierre Becquemin; Alain Luciani; Alain Rahmouni; Hicham Kobeiter
Journal:  J Vasc Interv Radiol       Date:  2013-09-12       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.